Hodgkin Lymphoma - Relapsed/Refractory
Sort by:
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Advanced Stage Hodgkin Lymphoma: New EvIdence in Induction, Treatment Intensification in PET2+ Disease, 1st Salvage Settings - Brentuximab w/ or w/o Chemo Regimens, Brentuximab + anti-PD-1
FEATURING
Pier Luigi Zinzani
- 405 views
- October 18, 2019
- 2
Indy Hematology Review
Hodgkin Lymphoma - Revolutionized Treatment Options Using Brentuximab Vedotin and Checkpoint Inhibitors
FEATURING
Bruce Cheson
- 394 views
- June 7, 2019
- 2
2018 Pan Pacific Lymphoma Conference
Hodgkin Lymphoma: First Relapse Options
FEATURING
Barbara Pro
- 87 views
- January 10, 2019
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract SCT 020: Incidence, Risk Factors and Treatment Response in Patients with Chronic Graft Versus-Host Disease After Haploidentical Transplantation with Post-Transplantation Cyclophosphamide
FEATURING
Daniel Rivera
- 32 views
- November 5, 2018
2018 Pan Pacific Lymphoma Conference
Beyond Standard Chemotherapy Novel Agents and Appraoches in HL
FEATURING
Barbara Pro
- 256 views
- October 2, 2018
- 2
2018 Pan Pacific Lymphoma Conference
Beyond Checkpoint Inhibitors for Hodgkin Lymphoma
FEATURING
Stephen M. Ansell
- 42 views
- August 23, 2018
2018 Pan Pacific Lymphoma Conference
Evalutation of patients for ASCT in Relapsed Refractory Hodgkin Lymphoma
FEATURING
Craig Moskowitz
- 38 views
- August 15, 2018
2018 Pan Pacific Lymphoma Conference
Relapsed and Primary Refractory Hodgkin Lymphoma in the Near Future
FEATURING
Craig Moskowitz
- 60 views
- August 15, 2018
2018 Pan Pacific Lymphoma Conference
Radiation Therapy for nondular lymphocyte predominant Hodgkin Lymphoma
FEATURING
Richard Hoppe
- 29 views
- August 15, 2018
Catherine Diefenbach
Beyond transplant: Relapsed and Refractory Hodgkin Lymphoma
- 46 views
- August 14, 2018
Indy Hematology Review
Emerging Strategies and Treatment in Hodgkin Lymphoma
FEATURING
Bruce Cheson
- 355 views
- April 12, 2018
- 1